Dr Reddy’s receives EIR for API manufacturing facility

Inspection concluded at its API manufacturing facility in Srikakulam, Andhra Pradesh

The United States Food and Drug Administration (USFDA) concluded its inspection of Dr Reddy’s Laboratories’ API manufacturing facility in Srikakulam, Andhra Pradesh.

Dr Reddy’s received an Establishment Inspection Report (EIR) and the USFDA classified the inspection as Voluntary Action Indicated (VAI).

API manufacturingDr Reddy's Laboratoriesfacility inspectionpharma newsUSFDA
Comments (0)
Add Comment